The story of the blue pill offers a complex case study for analysts eyeing pharma. While early sales were explosive, current patent lapse and the arrival of generic versions have significantly influenced earnings. https://victordzfh753987.ampblogs.com/the-blue-pill-and-pharma-a-precarious-stake-77923818